Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein

[AndhraPickles]

https://www.sciencedirect.com/science/article/pii/S0042682214000051

 

Virology

Volumes 452–453, March 2014, Pages 32-41

[AndhraPickles]

Ltt

[AndhraPickles]

Ltt

[yoda123]

it got academic and theoretic significance .. i do wonder the value in reality ... 

as most of the population across the world is vaccinated against Measles ... but we are still seeing corona infections ...

[Marsmangalodu]

2013 paper on sars..the current one is sars-cov2

[AndhraPickles]

41 minutes ago, yoda123 said:

it got academic and theoretic significance .. i do wonder the value in reality ... 

as most of the population across the world is vaccinated against Measles ... but we are still seeing corona infections ...

What about the mmr titers -vs- covid severity study ....can a strong booster dose reduce the deaths atleast...

 

Taken together, our finding that 14 years is the mean age at which mumps titers fall below 134 AU/ml and our finding that mumps titers above this value (in the MMR II group) were exclusively associated with functionally immune and asymptomatic individuals suggest that age 14 years would be the pivot point after which a further decline in mumps titers would be associated with a sharp rise in age-related risk of a COVID-19-positive test result or having a symptomatic case. The CDC data that we reviewed indeed indicated that the age of 14 years is the pivot point at which both the incidence of COVID-19-positive cases and the risk of death begin to rise sharply. We acknowledge that the sharp rise in the incidence of cases at age 14 years may also be influenced by other factors; however, this association adds further support to the hypothesis that MMR II-induced immunity may be a significant factor in protecting vaccinated children through age 14 years from COVID-19, in addition to protecting older adults with adequate mumps titers.

In the United States, there have been 65% more COVID-19 cases diagnosed in infants less than 12 months of age than in children 2 years of age. The increase in the number of cases in infants less than 12 months of age might also be related to an association between MMR II and COVID-19 because infants do not receive their first MMR II vaccination until 12 to 15 months of age. Those infants who are protected might be protected by transplacentally acquired MMR antibodies lasting up to 6 months of age (14). A study in China further supported age-related associations in children. While COVID-19-positive children aged 1 to 15 years were found to be asymptomatic 3.1% to 6.5% of the time, infants less than 1 year of age in China were asymptomatic only 1.9% of the time. Further, children in that Chinese study who were aged 1 to 15 years had critical COVID-19 illness no more than 0.7% of the time, while those less than 1 year of age had critical illness 1.9% of the time (15).

[sri_sri999]

19 hours ago, AndhraPickles said:

https://www.sciencedirect.com/science/article/pii/S0042682214000051

 

Virology

Volumes 452–453, March 2014, Pages 32-41

Flu vaccine kuda some protection estundi ani UK and Ireland lo antunaru

[AndhraPickles]

5 hours ago, sri_sri999 said:

Flu vaccine kuda some protection estundi ani UK and Ireland lo antunaru

But MMR is genetically similar to sars-cov-19 w.r.t glycoprotein spikes...